AI + Thermal Camera + Smartphone

Early detection of breast cancer with cutting edge technology

Breast cancer is the most common cancer for women globally, with a 15 % mortality rate. Early detection increases the chances for successful treatment and survival.

To be the first to know more, leave your e-mail down below and join us on our quest.

Thermaiscan provides a non-invasive, portable and cost effective pre-screening tool for health care providers.

AI + Thermal Camera + Smartphone

Early detection of breast cancer with cutting edge technology

Breast cancer is the most common cancer for women globally, with a 15 % mortality rate. Early detection increases the chances for successful treatment and survival.

ThermaiScan provides a non-invasive, portable and cost effective risk assessment tool for health care providers.​

To be the first to know more, leave your e-mail down below and join us on our quest.

close-up-stethoscope-pink-ribbon_23-2147738547-2

The problem

15 % of women with breast cancer die

Breast cancer is a serious global public health issue and the most common cancer for women, with a staggering 15 % mortality rate world wide. 70 % of breast cancer deaths today occur in low- and middle income countries, mainly due to late detection. 

Our solution

Pocket-sized pre-screening tool, limitless impact

By combining thermal imaging technology and artificial intelligence, our pre-scanning tool can detect even the smallest abnormalities in breast tissue. It is a safe, cost effective and non-invasive tool to be used by health care professionals in breast cancer screenings.
thermai_image
63177-scaled

For investors

Saving lives, one screening at the time.

There are limitless possibilities within health tech and predictive medicine with our core technology. Our algorithm and technical competence within thermal imaging and AI can be applied to many areas. We are currently looking for investors sharing our vision.

Recent News

Be part of our journey

Leave your email to receive updates